{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:13:54Z","timestamp":1790730834120,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jaad.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jaad.2017.10.048","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T20:17:46Z","timestamp":1510172266000},"page":"470-478.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Objective outcome measures: Collecting meaningful data on alopecia areata"],"prefix":"10.1016","volume":"79","author":[{"given":"Elise A.","family":"Olsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"McMichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Bergfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Callender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paradi","family":"Mirmirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Washenik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Whiting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Cotsarelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Hordinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2017.10.048_bib1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975-1989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2017.10.048_bib2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/jid.2013.464","article-title":"Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009","volume":"134","author":"Mirzoyev","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib3","series-title":"Ringworm and Alopecia Areata. Their Pathology, Diagnosis and Treatment","author":"Aldersmith","year":"1897"},{"key":"10.1016\/j.jaad.2017.10.048_bib4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1749-6632.1960.tb40921.x","article-title":"Evaluation of disturbed hair growth in alopecia areata and other alopecias","volume":"83","author":"Van Scott","year":"1959","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaad.2017.10.048_bib5","series-title":"Disorders of Hair Loss: Diagnosis and Treatment.","article-title":"Clinical tools for assessing hair loss","author":"Olsen","year":"2003"},{"key":"10.1016\/j.jaad.2017.10.048_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-0960.2012.00946.x","article-title":"Exclamation marks and other trichoscopic signs of chemotherapy induced alopecia","volume":"54","author":"Pirmez","year":"2013","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib7","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jaad.2012.02.013","article-title":"Hair and scalp dermoscopy","volume":"67","author":"Miteva","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0190-9622(99)70195-7","article-title":"Alopecia areata investigative guidelines","volume":"40","author":"Olsen","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/jid.1950.52","article-title":"Alopecia areata. A statistical study and consideration of endocrine influences","volume":"14","author":"Walker","year":"1950","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2006.05.008","article-title":"Alopecia areata: a long term follow-up study of 191 patients","volume":"55","author":"Tosti","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2230.1989.tb02604.x","article-title":"Juvenile versus maturity-onsopecia areata\u2014a comparative retrospective clinical study","volume":"14","author":"De Waard-van der Spek","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib12","first-page":"757","article-title":"HLA class II antigen associations help to define two types of alopecia areata","volume":"33","author":"Colombe","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib13","first-page":"1063","article-title":"Predictive model for immunotherapy of alopecia areata with diphencyprone","volume":"137","author":"Wiseman","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib14","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jaad.2012.06.006","article-title":"Multivariate analysis of prognostic factors in patients with rapidly progressive alopecia areata","volume":"67","author":"Uchiyama","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.jaad.2017.10.048_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0190-9622(91)70032-W","article-title":"Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone","volume":"24","author":"van der Steen","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2133.2003.05535.x","article-title":"Guidelines for the management of alopecia areata","volume":"149","author":"MacDonald Hull","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1529-8019.2011.01415.x","article-title":"Investigative guidelines for alopecia areata","volume":"24","author":"Olsen","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2017.10.048_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000254503","article-title":"A new classification of alopecia areata","volume":"131","author":"Ikeda","year":"1965","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2017.10.048_bib19","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1136\/bmj.2.4691.1250","article-title":"Alopecia areata: a clinical study","volume":"2","author":"Anderson","year":"1950","journal-title":"Br Med J"},{"key":"10.1016\/j.jaad.2017.10.048_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1523-1747.2003.12165.x","article-title":"Alopecia areata: treatment of today and tomorrow","volume":"8","author":"Freyschmidt-Paul","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2017.10.048_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000246337","article-title":"Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance","volume":"192","author":"Weise","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.10.048_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2017.10.048_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-4362.1985.tb05351.x","article-title":"Alopecia areata","volume":"24","author":"Nelson","year":"1985","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib24","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archderm.1992.01680210045005","article-title":"Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata","volume":"128","author":"Olsen","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib25","first-page":"20","article-title":"Topical and systemic corticosteroids in alopecia areata","volume":"38","author":"Olsen","year":"1997","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines\u2014part II","volume":"51","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib27","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archderm.139.12.1555","article-title":"Histopathologic features of alopecia areata: a new look","volume":"139","author":"Whiting","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib28","unstructured":"Olsen EA, Green C, Hordinsky M, et\u00a0al. Alopecia Density and Extent Score (ALODEX): a new method for assessing severity of hair loss in alopecia areata. In press."},{"key":"10.1016\/j.jaad.2017.10.048_bib29","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jaad.2016.08.042","article-title":"SALT II: a new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss","volume":"75","author":"Olsen","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000442816","article-title":"Alopecia areata progression index, a scoring system for evaluating overall hair loss activity in alopecia areata patients with pigmented hair: a development and reliability assessment","volume":"232","author":"Jang","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.10.048_bib31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0733-8635(18)30255-9","article-title":"Topical immunotherapy of alopecia areata. What, how, and why?","volume":"11","author":"van der Steen","year":"1993","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2017.10.048_bib32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2230.2000.00726.x","article-title":"Development of a health-related quality of life questionnaire for women with androgenetic alopecia","volume":"25","author":"Dolte","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/120347540100500202","article-title":"Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin disease","volume":"5","author":"Chren","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2017.10.048_bib34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1468-3083.2001.00336.x","article-title":"Assessing psychological distress in patients with skin diseases: reliability, validity and factor structure of the GHQ-12","volume":"15","author":"Picardi","year":"2001","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"10.1016\/j.jaad.2017.10.048_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1468-3083.2001.00229.x","article-title":"The effect of hair loss on quality of life","volume":"15","author":"Williamson","year":"2001","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"10.1016\/j.jaad.2017.10.048_bib36","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1038\/jidsymp.2013.19","article-title":"Development of the alopecia areata symptom impact scale","volume":"16","author":"Mendoza","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2017.10.048_bib37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaad.2011.10.027","article-title":"Global photographic assessment of men age 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo","volume":"67","author":"Olsen","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib38","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2012.10955.x","article-title":"British Association of Dermatologists\u2019 guidelines for the management of alopecia areata 2012","volume":"166","author":"Messenger","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.048_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2007.10.645","article-title":"Subcutaneous efalizumab is not effective in the treatment of alopecia areata","volume":"58","author":"Price","year":"2008","journal-title":"J Am Acad Dermatol"}],"updated-by":[{"DOI":"10.1016\/j.jaad.2023.10.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000}}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217326142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217326142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T08:05:26Z","timestamp":1534320326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217326142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0190962217326142"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.10.048","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Objective outcome measures: Collecting meaningful data on alopecia areata","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.10.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}